AdvaMed’s Comments on EPA Sterilization Emissions Standards
AdvaMed outlines recommendations to ensure EPA’s proposed ethylene oxide (EtO) emissions standards protect public health while maintaining access to life-saving medtech.
Ethylene Oxide
Learn more about our Ethylene Oxide & Sterilization work.
AdvaMed® Urges Georgia Court of Appeals to Enforce Sound Science in Ethylene Oxide Litigation
WASHINGTON—AdvaMed, the MedTech Association®, the world’s largest medtech trade association, representing over 650 medical technology innovators, has filed an amicus curiae brief in the Walker v. Becton, Dickinson and Company…
AdvaMed® Anticipates EtO Sterilization Rule, Voices Concern About Impact on Patient Care
By Friday, March 1, the Environmental Protection Agency is expected to finalize its regulation for the ethylene oxide (EtO) sterilization of 20 billion, or half, of all medical devices in…
Heart Surgeon, Small Medtech Company Leader Urges “Sensible” Sterilization Regulations, Cites Dire Consequences for Patients
In testimony today before the U.S. House of Representatives Committee on Small Business, Dr. Lishan Aklog urged Congress and the executive branch to consider the dire consequences for patients and…
AdvaMed® to Congress: EPA’s Proposed EtO Regulations Put Patient Care at Risk
In testimony today before a key congressional subcommittee hearing, AdvaMed, The Medtech Association®, called for a balance in the proposed regulations of the method used to sterilize 20 billion, or…
Building Medtech Connections and Why They Matter
Scott Whitaker, president and CEO of AdvaMed®, recently chatted with Joe Mullings, chairman and CEO of The Mullings Group, about the impact of the medtech industry and the importance of…
Medtech Sterilization and Patient Care: The Critical Role of Ethylene Oxide
Ethylene oxide sterilization ensures billions of pieces of medical technology are sterile for patients in every medical setting, in surgical procedures from c-sections to knee replacements.
Op-ed: Risk, Regulation, and Reality Checks: The Example of Ethylene Oxide
According to a senior toxicologist in a RealClearPolicy op-ed, the EPA draws unreasonable conclusions about the health risks of the ethylene oxide used to sterilize medical technology.
AdvaMed®: EPA Proposals Create Significant Risk of a Healthcare Crisis
In comments filed with the Environment Protection Agency (EPA) today, AdvaMed, The Medtech Association®, called for continued cooperation between the industry and the agency as the regulations covering medical device…
AdvaMed® Welcomes EPA Extension of Comment Period for Complex Medtech Sterilization Regulations, Says There’s “Not Nearly Enough” Time to Review Proposals Critical to Public Health
AdvaMed, The Medtech Association®, today welcomed the U.S. Environmental Protection Agency (EPA) extension of 15 more days for public comment on two proposed updates to regulations governing the use of…